Polyrizon Ltd.
corporate_fare Company Profile
Polyrizon Ltd. (NASDAQ:PLRZ) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors PLRZ SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Polyrizon's NASARIX™ Allergy Blocker Successfully Completes Biocompatibility Program
- Polyrizon's NASARIX™ Allergy Blocker Clears Biocompatibility Testing, Paving Way for Human Trials
- Polyrizon's Allergy Blocker Trial Receives Central IRB Approval, Advancing Towards Patient Enrollment
- Polyrizon's Mucoadhesive Drug Delivery Platform Patent Application Published
- Polyrizon Initiates Key Human Study for NASARIX™ Allergy Blocker to Support FDA Pathway
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for PLRZ, detected from its recent SEC filings · based on capital-structure filings through 2026-04-23.
Capital Raise Finalized · Deep Discount Pricing
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
PLRZ files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.